The molecular tests performed were those standardized for B-ALL diagnosis including: ETV6-RUNX1, TCF3-PBX1, BCR-ABL1, P2RY8-CRLF2 and KMT2A-AFF1 for 220 samples. Here, PBX1 is linked to acute lymphoblastic leukemia.